Clinical Trial Update: Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on circulating tumor cells in patients with neuroendocrine tumours treated with Somatuline Autogel.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumors

Drugs mentioned

• Somatuline Autogel (lanreotide)

Snippet

Sponsor: Ipsen | Conditions: NeuroEndocrine Tumours | Phase 4 | Status: COMPLETED | Results posted: 2019-06-07